本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

188.44
-5.5100-2.84%
盘后:189.551.11+0.59%18:29 EDT
成交量:294.16万
成交额:5.58亿
市值:403.90亿
市盈率:-21.12
高:193.61
开:191.57
低:187.14
收:193.95
52周最高:224.31
52周最低:47.45
股本:2.14亿
流通股本:1.85亿
量比:1.27
换手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.50
市盈率(LYR):-31.67

数据加载中...

2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/23

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/06

重要事件披露

Form 8-K - Current report